Rhomboid protease inhibitors: Emerging tools and future therapeutics

Seminars in Cell and Developmental Biology

Volumn 60, Issue , 2016, Pages 52-62

  Strisovsky, Kvido ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Disease; Inhibitor; Mechanism; Rhomboid protease; Substrate specificity

Indexed keywords

RHOMBOID PROTEASE; RHOMBOID PROTEASE INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PROTEINASE INHIBITOR;

DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SPECIFICITY; FUTUROLOGY; HUMAN; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYME ASSAY; METABOLISM; MOLECULARLY TARGETED THERAPY;

ANIMALS; ENZYME ASSAYS; HUMANS; MEMBRANE PROTEINS; MOLECULAR TARGETED THERAPY; PROTEASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 84994680422     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2016.08.021     Document Type: Review

References (97)

1. [1] Urban, S., Lee, J.R., Freeman, M., Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases. Cell 107:2 (2001), 173–182.
2. [2] Urban, S., Lee, J.R., Freeman, M., A family of Rhomboid intramembrane proteases activates all Drosophila membrane-tethered EGF ligands. EMBO J. 21:16 (2002), 4277–4286.
3. [3] Koonin, E.V., Makarova, K.S., Rogozin, I.B., Davidovic, L., Letellier, M.C., Pellegrini, L., The rhomboids: a nearly ubiquitous family of intramembrane serine proteases that probably evolved by multiple ancient horizontal gene transfers. Genome Biol., 4(3), 2003, R19.
4. [4] Freeman, M., The rhomboid-like superfamily: molecular mechanisms and biological roles. Annu. Rev. Cell Dev. Biol. 30 (2014), 235–254.
5. [5] Adrain, C., Zettl, M., Christova, Y., Taylor, N., Freeman, M., Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335:6065 (2012), 225–228.
6. [6] McIlwain, D.R., Lang, P.A., Maretzky, T., Hamada, K., Ohishi, K., Maney, S.K., Berger, T., Murthy, A., Duncan, G., Xu, H.C., Lang, K.S., Haussinger, D., Wakeham, A., Itie-Youten, A., Khokha, R., Ohashi, P.S., Blobel, C.P., Mak, T.W., iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335:6065 (2012), 229–232.
7. [7] Issuree, P.D., Maretzky, T., McIlwain, D.R., Monette, S., Qing, X., Lang, P.A., Swendeman, S.L., Park-Min, K.H., Binder, N., Kalliolias, G.D., Yarilina, A., Horiuchi, K., Ivashkiv, L.B., Mak, T.W., Salmon, J.E., Blobel, C.P., iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. J. Clin. Invest. 123:2 (2013), 928–932.
8. [8] Li, X., Maretzky, T., Weskamp, G., Monette, S., Qing, X., Issuree, P.D., Crawford, H.C., McIlwain, D.R., Mak, T.W., Salmon, J.E., Blobel, C.P., iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling. Proc. Natl. Acad. Sci. U. S. A. 112:19 (2015), 6080–6085.
9. [9] Maney, S.K., McIlwain, D.R., Polz, R., Pandyra, A.A., Sundaram, B., Wolff, D., Ohishi, K., Maretzky, T., Brooke, M.A., Evers, A., Vasudevan, A.A., Aghaeepour, N., Scheller, J., Munk, C., Haussinger, D., Mak, T.W., Nolan, G.P., Kelsell, D.P., Blobel, C.P., Lang, K.S., Lang, P.A., Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17. Sci. Signal., 8(401), 2015, ra109.
10. [10] Siggs, O.M., Grieve, A., Xu, H., Bambrough, P., Christova, Y., Freeman, M., Genetic interaction implicates iRhom2 in the regulation of EGF receptor signalling in mice. Biol. Open 3:12 (2014), 1151–1157.
11. [11] Santos, J.M., Graindorge, A., Soldati-Favre, D., New insights into parasite rhomboid proteases. Mol. Biochem. Parasitol. 182:1-2 (2012), 27–36.
12. [12] Sibley, L.D., The roles of intramembrane proteases in protozoan parasites. Biochim. Biophys. Acta 1828:12 (2013), 2908–2915.
13. [13] Riestra, A.M., Gandhi, S., Sweredoski, M.J., Moradian, A., Hess, S., Urban, S., Johnson, P.J., A trichomonas vaginalis rhomboid protease and its substrate modulate parasite attachment and cytolysis of host cells. PLoS Pathog., 11(12), 2015, e1005294.
14. [14] Baxt, L.A., Rastew, E., Bracha, R., Mirelman, D., Singh, U., Downregulation of an entamoeba histolytica rhomboid protease reveals roles in regulating parasite adhesion and phagocytosis. Eukaryot. Cell 9:8 (2010), 1283–1293.
15. [15] Baxt, L.A., Baker, R.P., Singh, U., Urban, S., An Entamoeba histolytica rhomboid protease with atypical specificity cleaves a surface lectin involved in phagocytosis and immune evasion. Genes Dev. 22:12 (2008), 1636–1646.
16. [16] Baker, R.P., Wijetilaka, R., Urban, S., Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria. PLoS Pathog., 2(10), 2006, e113.
17. [17] O'Donnell, R.A., Hackett, F., Howell, S.A., Treeck, M., Struck, N., Krnajski, Z., Withers-Martinez, C., Gilberger, T.W., Blackman, M.J., Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite. J. Cell Biol. 174:7 (2006), 1023–1033.
18. [18] Lin, J.W., Meireles, P., Prudencio, M., Engelmann, S., Annoura, T., Sajid, M., Chevalley-Maurel, S., Ramesar, J., Nahar, C., Avramut, C.M., Koster, A.J., Matuschewski, K., Waters, A.P., Janse, C.J., Mair, G.R., Khan, S.M., Loss-of-function analyses defines vital and redundant functions of the Plasmodium rhomboid protease family. Mol. Microbiol. 88:2 (2013), 318–338.
19. [19] Vaknin, Y., Hillmann, F., Iannitti, R., Ben Baruch, N., Sandovsky-Losica, H., Shadkchan, Y., Romani, L., Brakhage, A., Kniemeyer, O., Osherov, N., Identification and, Characterization of a novel aspergillus fumigatus rhomboid family putative protease, RbdA, involved in hypoxia sensing and virulence. Infect. Immun. 84:6 (2016), 1866–1878.
20. [20] Stevenson, L.G., Strisovsky, K., Clemmer, K.M., Bhatt, S., Freeman, M., Rather, P.N., Rhomboid protease AarA mediates quorum-sensing in Providencia stuartii by activating TatA of the twin-arginine translocase. Proc. Natl. Acad. Sci. U. S. A. 104:3 (2007), 1003–1008.
21. [21] Mesak, L.R., Mesak, F.M., Dahl, M.K., Expression of a novel gene, gluP, is essential for normal Bacillus subtilis cell division and contributes to glucose export. BMC Microbiol., 4, 2004, 13.
22. [22] Parente, J., Casabuono, A., Ferrari, M.C., Paggi, R.A., De Castro, R.E., Couto, A.S., Gimenez, M.I., A rhomboid protease gene deletion affects a novel oligosaccharide N-linked to the S-layer glycoprotein of Haloferax volcanii. J. Biol. Chem. 289:16 (2014), 11304–11317.
23. [23] Kateete, D.P., Katabazi, F.A., Okeng, A., Okee, M., Musinguzi, C., Asiimwe, B.B., Kyobe, S., Asiimwe, J., Boom, W.H., Joloba, M.L., Rhomboids of mycobacteria: characterization using an aarA mutant of providencia stuartii and gene deletion in mycobacterium smegmatis. PLoS One, 7(9), 2012, e45741.
24. [24] Kinch, L.N., Grishin, N.V., Bioinformatics perspective on rhomboid intramembrane protease evolution and function. Biochim. Biophys. Acta 1828:12 (2013), 2937–2943.
25. [25] Blobel, C.P., ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6:1 (2005), 32–43.
26. [26] Saftig, K., The a disintegrin and metalloproteases ADAM10 and ADAM17: novel drug targets with therapeutic potential?. Eur. J. Cell Biol. 90:6–7 (2011), 527–535.
27. [27] Brooke, M.A., Etheridge, S.L., Kaplan, N., Simpson, C., O'Toole, E.A., Ishida-Yamamoto, A., Marches, O., Getsios, S., Kelsell, D.P., iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function. Hum. Mol. Genet. 23:15 (2014), 4064–4076.
28. [28] Hosur, V., Johnson, K.R., Burzenski, L.M., Stearns, T.M., Maser, R.S., Shultz, L.D., Rhbdf2 mutations increase its protein stability and drive EGFR hyperactivation through enhanced secretion of amphiregulin. Proc. Natl. Acad. Sci. U. S. A. 111:21 (2014), E2200–9.
29. [29] Christova, Y., Adrain, C., Bambrough, P., Ibrahim, A., Freeman, M., Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation. EMBO Rep. 14:10 (2013), 884–890.
30. [30] Adrain, C., Strisovsky, K., Zettl, M., Hu, L., Lemberg, M.K., Freeman, M., Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep. 12:5 (2011), 421–427.
31. [31] Liao, H.J., Carpenter, G., Regulated intramembrane cleavage of the EGF receptor. Traffic 13:8 (2012), 1106–1112.
32. [32] Song, W., Liu, W., Zhao, H., Li, S., Guan, X., Ying, J., Zhang, Y., Miao, F., Zhang, M., Ren, X., Li, X., Wu, F., Zhao, Y., Tian, Y., Wu, W., Fu, J., Liang, J., Wu, W., Liu, C., Yu, J., Zong, S., Miao, S., Zhang, X., Wang, L., Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway. Nat. Commun., 6, 2015, 8022.
33. [33] Lemberg, M.K., Freeman, M., Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases. Genome Res. 17:11 (2007), 1634–1646.
34. [34] Lohi, O., Urban, S., Freeman, M., Diverse substrate recognition mechanisms for rhomboids; thrombomodulin is cleaved by Mammalian rhomboids. Curr. Biol. 14:3 (2004), 236–241.
35. [35] Cheng, T.L., Wu, Y.T., Lin, H.Y., Hsu, F.C., Liu, S.K., Chang, B.I., Chen, W.S., Lai, C.H., Shi, G.Y., Wu, H.L., Functions of rhomboid family protease RHBDL2 and thrombomodulin in wound healing. J. Invest. Dermatol. 131:12 (2011), 2486–2494.
36. [36] Noy, P.J., Swain, R.K., Khan, K., Lodhia, P., Bicknell, R., Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2). FASEB J. 30:6 (2016), 2311–2323.
37. [37] Cheng, T.L., Lai, C.H., Jiang, S.J., Hung, J.H., Liu, S.K., Chang, B.I., Shi, G.Y., Wu, H.L., RHBDL2 is a critical membrane protease for anoikis resistance in human malignant epithelial cells. Sci. World J., 2014, 2014, 902987.
38. [38] Canzoneri, R., Lacunza, E., Isla Larrain, M., Croce, M.V., Abba, M.C., Rhomboid family gene expression profiling in breast normal tissue and tumor samples. Tumour Biol. 35:2 (2014), 1451–1458.
39. [39] Fleig, L., Bergbold, N., Sahasrabudhe, P., Geiger, B., Kaltak, L., Lemberg, M.K., Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins. Mol. Cell 47:4 (2012), 558–569.
40. [40] Wunderle, L., Knopf, J.D., Kuhnle, N., Morle, A., Hehn, B., Adrain, C., Strisovsky, K., Freeman, M., Lemberg, M.K., Rhomboid intramembrane protease RHBDL4 triggers ER-export and non-canonical secretion of membrane-anchored TGFalpha. Sci. Rep., 6, 2016, 27342.
41. [41] Pascall, J.C., Brown, K.D., Characterization of a mammalian cDNA encoding a protein with high sequence similarity to the Drosophila regulatory protein Rhomboid. FEBS Lett. 429:3 (1998), 337–340.
42. [42] Jaszai, J., Brand, M., Cloning and expression of Ventrhoid, a novel vertebrate homologue of the Drosophila EGF pathway gene rhomboid. Mech. Dev. 113:1 (2002), 73–77.
43. [43] Petri, A., Ahnfelt-Ronne, J., Frederiksen, K.S., Edwards, D.G., Madsen, D., Serup, P., Fleckner, J., Heller, R.S., The effect of neurogenin3 deficiency on pancreatic gene expression in embryonic mice. J. Mol. Endocrinol. 37:2 (2006), 301–316.
44. [44] Kumar, A., Gibbs, J.R., Beilina, A., Dillman, A., Kumaran, R., Trabzuni, D., Ryten, M., Walker, R., Smith, C., Traynor, B.J., Hardy, J., Singleton, A.B., Cookson, M.R., Age-associated changes in gene expression in human brain and isolated neurons. Neurobiol. Aging 34:4 (2013), 1199–1209.
45. [45] Wolf, E.V., Zeissler, A., Verhelst, S.H., Inhibitor fingerprinting of rhomboid proteases by activity-Based protein profiling reveals inhibitor selectivity and rhomboid autoprocessing. ACS Chem. Biol. 10:10 (2015), 2325–2333.
46. [46] Cipolat, S., Rudka, T., Hartmann, D., Costa, V., Serneels, L., Craessaerts, K., Metzger, K., Frezza, C., Annaert, W., D'Adamio, L., Derks, C., Dejaegere, T., Pellegrini, L., D'Hooge, R., Scorrano, L., De Strooper, B., Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126:1 (2006), 163–175.
47. [47] Chan, E.Y., McQuibban, G.A., The mitochondrial rhomboid protease: its rise from obscurity to the pinnacle of disease-relevant genes. Biochim. Biophys. Acta 1828:12 (2013), 2916–2925.
48. [48] Meissner, C., Lorenz, H., Hehn, B., Lemberg, M.K., Intramembrane protease PARL defines a negative regulator of PINK1- and PARK2/Parkin-dependent mitophagy. Autophagy 11:9 (2015), 1484–1498.
49. [49] Chu, C.T., A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease. Hum. Mol. Genet. 19:R1 (2010), R28–37.
50. [50] Exner, N., Lutz, A.K., Haass, C., Winklhofer, K.F., Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 31:14 (2012), 3038–3062.
51. [51] Abou-Sleiman, P.M., Muqit, M.M., Wood, N.W., Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 7:3 (2006), 207–219.
52. [52] Szendroedi, J., Phielix, E., Roden, M., The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8:2 (2012), 92–103.
53. [53] Hedstrom, L., Serine protease mechanism and specificity. Chem. Rev. 102:12 (2002), 4501–4524.
54. [54] Wang, Y., Zhang, Y., Ha, Y., Crystal structure of a rhomboid family intramembrane protease. Nature 444:7116 (2006), 179–180.
55. [55] Uritsky, N., Shokhen, M., Albeck, A., The catalytic machinery of rhomboid proteases: combined MD and QM simulations. J. Chem. Theory Comput. 8:11 (2012), 4663–4671.
56. [56] Uritsky, N., Shokhen, M., Albeck, A., Stepwise versus concerted mechanisms in general-Base catalysis by serine proteases. Angew. Chem. Int. Ed. Engl. 55:5 (2016), 1680–1684.
57. [57] Wu, Z., Yan, N., Feng, L., Oberstein, A., Yan, H., Baker, R.P., Gu, L., Jeffrey, P.D., Urban, S., Shi, Y., Structural analysis of a rhomboid family intramembrane protease reveals a gating mechanism for substrate entry. Nat. Struct. Mol. Biol. 13:12 (2006), 1084–1091.
58. [58] Lemieux, M.J., Fischer, S.J., Cherney, M.M., Bateman, K.S., James, M.N., The crystal structure of the rhomboid peptidase from Haemophilus influenzae provides insight into intramembrane proteolysis. Proc. Natl. Acad. Sci. USA 104:3 (2007), 750–754.
59. [59] James, M.N.G., Convergence of active-center geometries among the proteolytic-enzymes. Bond, J.S., Barrett, A.J., (eds.) Proteolysis and Protein Turnover, 1993, Portland Press Ltd., London, 1–8.
60. [60] Ekici, DD.a., Paetzel, M., Dalbey, R.E., Unconventional serine proteases: variations on the catalytic Ser/His/Asp triad configuration. Protein Sci. 17:12 (2008), 2023–2037.
61. [61] Paetzel, M., Dalbey, R.E., Strynadka, N.C., Crystal structure of a bacterial signal peptidase in complex with a beta-lactam inhibitor. Nature 396:6707 (1998), 186–190.
62. [62] Henderson, R., Structure of crystalline alpha-chymotrypsin. IV. The structure of indoleacryloyl-alpha-chyotrypsin and its relevance to the hydrolytic mechanism of the enzyme. J. Mol. Biol. 54:2 (1970), 341–354.
63. [63] Zhou, Y., Moin, S.M., Urban, S., Zhang, Y., An internal water-retention site in the rhomboid intramembrane protease GlpG ensures catalytic efficiency. Structure 20:7 (2012), 1255–1263.
64. [64] Timmer, J.C., Zhu, W., Pop, C., Regan, T., Snipas, S.J., Eroshkin, A.M., Riedl, S.J., Salvesen, G.S., Structural and kinetic determinants of protease substrates. Nat. Struct. Mol. Biol. 16:10 (2009), 1101–1108.
65. [65] Madala, P.K., Tyndall, J.D., Nall, T., Fairlie, D.P., Update 1 of: proteases universally recognize beta strands in their active sites. Chem. Rev. 110:6 (2010), PR1–31.
66. [66] Tyndall, J.D., Nall, T., Fairlie, D.P., Proteases universally recognize beta strands in their active sites. Chem. Rev. 105:3 (2005), 973–999.
67. [67] Li, S.C., Deber, C.M., A measure of helical propensity for amino acids in membrane environments. Nat. Struct. Biol. 1:6 (1994), 368–373.
68. [68] Urban, S., Freeman, M., Substrate specificity of rhomboid intramembrane proteases is governed by helix-breaking residues in the substrate transmembrane domain. Mol. Cell 11:6 (2003), 1425–1434.
69. [69] Akiyama, Y., Maegawa, S., Sequence features of substrates required for cleavage by GlpG, an Escherichia coli rhomboid protease. Mol. Microbiol. 64:4 (2007), 1028–1037.
70. [70] Strisovsky, K., Sharpe, H.J., Freeman, M., Sequence-specific intramembrane proteolysis: identification of a recognition motif in rhomboid substrates. Mol. Cell 36:6 (2009), 1048–1059.
71. [71] Zoll, S., Stanchev, S., Began, J., Skerle, J., Lepsik, M., Peclinovska, L., Majer, P., Strisovsky, K., Substrate binding and specificity of rhomboid intramembrane protease revealed by substrate-peptide complex structures. EMBO J. 33:20 (2014), 2408–2421.
72. [72] Cho, S., Dickey, S.W., Urban, S., Crystal structures and inhibition kinetics reveal a two-stage catalytic mechanism with drug design implications for rhomboid proteolysis. Mol. Cell 61:3 (2016), 329–340.
73. [73] Dickey, S.W., Baker, R.P., Cho, S., Urban, S., Proteolysis inside the membrane is a rate-governed reaction not driven by substrate affinity. Cell 155:6 (2013), 1270–1281.
74. [74] Overall, C.M., Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol. Biotechnol. 22:1 (2002), 51–86.
75. [75] Copeland, R.A., Enzyme Reaction Mechanisms, Evaluation of Enzyme Inhibitors in Drug Discovery. 2013, John Wiley & Sons, Inc., 25–55.
76. [76] Radisky, E.S., Lee, J.M., Lu, C.J., Koshland, D.E. Jr., Insights into the serine protease mechanism from atomic resolution structures of trypsin reaction intermediates. Proc. Natl. Acad. Sci. U. S. A. 103:18 (2006), 6835–6840.
77. [77] Strisovsky, K., Why cells need intramembrane proteases – a mechanistic perspective. FEBS J. 283:10 (2016), 1837–1845.
78. [78] Langosch, D., Scharnagl, C., Steiner, H., Lemberg, M.K., Understanding intramembrane proteolysis: from protein dynamics to reaction kinetics. Trends Biochem. Sci. 40:6 (2015), 318–327.
79. [79] Urban, S., Moin, S.M., A subset of membrane-altering agents and gamma-secretase modulators provoke nonsubstrate cleavage by rhomboid proteases. Cell Rep. 8:5 (2014), 1241–1247.
80. [80] Moin, S.M., Urban, S., Membrane immersion allows rhomboid proteases to achieve specificity by reading transmembrane segment dynamics. eLife, 1, 2012, e00173.
81. [81] Urban, S., Schlieper, D., Freeman, M., Conservation of intramembrane proteolytic activity and substrate specificity in prokaryotic and eukaryotic rhomboids. Curr. Biol. 12:17 (2002), 1507–1512.
82. [82] Maegawa, S., Ito, K., Akiyama, Y., Proteolytic action of GlpG, a rhomboid protease in the Escherichia coli cytoplasmic membrane. Biochemistry 44:41 (2005), 13543–13552.
83. [83] Lemberg, M.K., Menendez, J., Misik, A., Garcia, M., Koth, C.M., Freeman, M., Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases. EMBO J. 24:3 (2005), 464–472.
84. [84] Urban, S., Wolfe, M.S., Reconstitution of intramembrane proteolysis in vitro reveals that pure rhomboid is sufficient for catalysis and specificity. Proc. Natl. Acad. Sci. U. S. A. 102:6 (2005), 1883–1888.
85. [85] Pierrat, O.A., Strisovsky, K., Christova, Y., Large, J., Ansell, K., Bouloc, N., Smiljanic, E., Freeman, M., Monocyclic beta-lactams are selective, mechanism-based inhibitors of rhomboid intramembrane proteases. ACS Chem. Biol. 6:4 (2011), 325–335.
86. [86] Vosyka, O., Vinothkumar, K.R., Wolf, E.V., Brouwer, A.J., Liskamp, R.M., Verhelst, S.H., Activity-based probes for rhomboid proteases discovered in a mass spectrometry-based assay. Proc. Natl. Acad. Sci. U. S. A. 110:7 (2013), 2472–2477.
87. [87] Arutyunova, E., Panwar, P., Skiba, P.M., Gale, N., Mak, M.W., Lemieux, M.J., Allosteric regulation of rhomboid intramembrane proteolysis. EMBO J. 33:17 (2014), 1869–1881.
88. [88] Bachovchin, D.A., Brown, S.J., Rosen, H., Cravatt, B.F., Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. Nat. Biotechnol. 27:4 (2009), 387–394.
89. [89] Wolf, E.V., Zeissler, A., Vosyka, O., Zeiler, E., Sieber, S., Verhelst, S.H., A new class of rhomboid protease inhibitors discovered by activity-based fluorescence polarization. PLoS One, 8(8), 2013, e72307.
90. [90] Xue, Y., Ha, Y., Catalytic mechanism of rhomboid protease GlpG probed by 3,4-dichloroisocoumarin and diisopropyl fluorophosphonate. J. Biol. Chem. 287:5 (2012), 3099–3107.
91. [91] Vinothkumar, K.R., Strisovsky, K., Andreeva, A., Christova, Y., Verhelst, S., Freeman, M., The structural basis for catalysis and substrate specificity of a rhomboid protease. EMBO J. 29:22 (2010), 3797–3809.
92. [92] Xue, Y., Chowdhury, S., Liu, X., Akiyama, Y., Ellman, J., Ha, Y., Conformational change in rhomboid protease GlpG induced by inhibitor binding to its S' subsites. Biochemistry 51:18 (2012), 3723–3731.
93. [93] Wolf, E.V., Seybold, M., Hadravova, R., Strisovsky, K., Verhelst, S.H., Activity-based protein profiling of rhomboid proteases in liposomes. ChemBioChem 16:11 (2015), 1616–1621.
94. [94] Vinothkumar, K.R., Pierrat, O.A., Large, J.M., Freeman, M., Structure of rhomboid protease in complex with beta-Lactam inhibitors defines the S2' cavity. Structure 21:6 (2013), 1051–1058.
95. [95] Walker, B., Lynas, J.F., Strategies for the inhibition of serine proteases. Cell. Mol. Life Sci. 58:4 (2001), 596–624.
96. [96] Das, C., Berezovska, O., Diehl, T.S., Genet, C., Buldyrev, I., Tsai, J.Y., Hyman, B.T., Wolfe, M.S., Designed helical peptides inhibit an intramembrane protease. J. Am. Chem. Soc. 125:39 (2003), 11794–11795.
97. [97] Hagemans, D., van Belzen, I.A., Moran Luengo, T., Rudiger, S.G., A script to highlight hydrophobicity and charge on protein surfaces. Front. Mol. Biosci., 2, 2015, 56.